12:00 AM
 | 
May 18, 2009
 |  BC Week In Review  |  Company News  |  Deals

Provid, American National Multiple Sclerosis Society deal

The society's not-for-profit technology transfer subsidiary Fast Forward LLC will provide $50,000 in funding for preclinical development of Provid's ...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >